A novel cohort analysis approach to determining the case fatality rate of COVID-19 and other infectious diseases

PLoS One. 2020 Jun 15;15(6):e0233146. doi: 10.1371/journal.pone.0233146. eCollection 2020.

Abstract

As the Coronavirus contagion develops, it is increasingly important to understand the dynamics of the disease. Its severity is best described by two parameters: its ability to spread and its lethality. Here, we combine a mathematical model with a cohort analysis approach to determine the range of case fatality rates (CFR). We use a logistical function to describe the exponential growth and subsequent flattening of COVID-19 CFR that depends on three parameters: the final CFR (L), the CFR growth rate (k), and the onset-to-death interval (t0). Using the logistic model with specific parameters (L, k and t0), we calculate the number of deaths each day for each cohort. We build an objective function that minimizes the root mean square error between the actual and predicted values of cumulative deaths and run multiple simulations by altering the three parameters. Using all of these values, we find out which set of parameters returns the lowest error when compared to the number of actual deaths. We were able to predict the CFR much closer to reality at all stages of the viral outbreak compared to traditional methods. This model can be used far more effectively than current models to estimate the CFR during an outbreak, allowing for better planning. The model can also help us better understand the impact of individual interventions on the CFR. With much better data collection and labeling, we should be able to improve our predictive power even further.

MeSH terms

  • Betacoronavirus
  • COVID-19
  • China / epidemiology
  • Cohort Studies
  • Computer Simulation
  • Coronavirus Infections / epidemiology
  • Coronavirus Infections / mortality*
  • Disease Outbreaks
  • Humans
  • Logistic Models*
  • Models, Biological*
  • Pandemics
  • Pneumonia, Viral / epidemiology
  • Pneumonia, Viral / mortality*
  • SARS-CoV-2

Grants and funding

The author received no specific funding for this work.